<![CDATA[Adult community-acquired pneumonia (CAP) contributes substantially to hospital admissions, especially among elderly and comorbid patients. Indonesia's PDPI guideline reports CAP incidence rising from 6 to 34 per 1,000 population between ages 18-39 and >75 years, with inpatient mortality of 5-20%. Levofloxacin is widely used empirically for its broad spectrum and rapid clinical improvement, yet local data on hospital stay and therapy duration remain limited. To describe hospital stay and levofloxacin duration by sex, age, CURB-65 score, and comorbidities, and their correlation among adult CAP patients at Gunung Jati Regional Hospital, Cirebon, 2025. Retrospective descriptive study using medical records, total sampling, and Spearman's correlation test. Of 55 patients, most were male (58.2%; consistent with Fésüs et al., 57.7%) and aged 45–64 years (47.3%). Leading comorbidities were cardiovascular disease (20.0%) and diabetes mellitus (14.5%). CURB-65 scores were mostly low-moderate (41.8% and 40.0%). Hospital stay and intravenous therapy were both most commonly 3–5 days (56.4% and 98.2%). CURB-65 correlated significantly but weakly with length of stay (r=0.290; p=0.032). Patients were predominantly middle-aged to older males with mild-to-moderate severity, hospitalized 3-5 days, and higher CURB-65 scores were linked to longer stays.]]>
Copyrights © 2026
